2,679 recalls tagged with “immediate action”.
Wizcure Pharmaa recalled 17,280 cartons of Vista Gel Hypromellose eye drops on December 31, 2025. The recall stems from a lack of assurance of sterility, raising potential health risks for users. Consumers should stop using the product immediately and contact their healthcare provider for guidance.
Wizcure Pharmaa recalled 5,760 cartons of Vista Tears Eye Drops on December 31, 2025. The recall follows a lack of assurance of sterility in the product. Consumers should stop using the drops immediately and contact a healthcare provider for guidance.
Wizcure Pharmaa Pvt. Ltd. recalled 139,104 cartons of Vista Gonio Eye Lubricant on December 31, 2025. The recall stems from a lack of assurance of sterility due to non-compliance with manufacturing practices. Consumers are urged to stop using the product immediately and seek guidance from healthcare providers.
Medica recalled 1,578 units of its Capillary Tubes on December 31, 2025. A systematic positive bias of up to 20% can produce false elevation results in patient potassium levels. Healthcare providers and patients must stop using the device immediately.
Wizcure Pharmaa recalled 10,080 boxes of Fluorescein Sodium Ophthalmic Strips on December 31, 2025, due to sterility issues. The recall affects products packaged in 100-count and 300-count boxes. Consumers should stop using these products immediately and consult healthcare providers for guidance.
Glenmark Pharmaceuticals recalled nearly 97,000 packs of Ondansetron Orally Disintegrating Tablets on December 30, 2025. Defective blister packs may not fully seal, leading to tablets falling out. Consumers should stop using the product immediately and contact healthcare providers.
Sun Pharmaceutical Industries is recalling 24,624 bottles of Fluocinolone Acetonide Topical Solution nationwide after out-of-spec impurity D was detected. The product is distributed by Taro Pharmaceuticals in the United States and labeled Rx-only. Consumers must stop using the product and consult a healthcare provider for guidance.
Zydus Pharmaceuticals recalled 22,896 bottles of Icosapent Ethyl capsules on December 30, 2025. The recall stems from leakage and oxidation that may reduce the drug's effectiveness. Consumers should stop using the product immediately and seek guidance from healthcare providers.
Intuitive Surgical recalled 47 da Vinci 5 Surgeon Console Viewer Displays on December 30, 2025. The devices may lose display functionality, risking surgical injury. Healthcare providers should stop using the consoles immediately and follow recall instructions.
Siemens Medical Solutions USA recalled 40 units of its LUMINOS Q.namix R X-ray system on December 29, 2025. The recall addresses a defect that may result in images being incorrectly processed, potentially showing images from previous patients. Healthcare providers should stop using the device immediately and follow recall instructions.
Cerapedics recalled 237 units of PearMatrix P-15 Peptide Enhanced Bone Graft on December 29, 2025. The recall affects products distributed nationwide after a review revealed incorrect expiration dates. Patients and healthcare providers should stop using the product immediately.
Siemens Medical Solutions USA recalled five LUMINOS Q.namix T X-ray systems on December 29, 2025. The recall affects devices that can process images from previous patients due to a software issue. Healthcare providers must stop using these devices immediately.
Gold Star Distribution recalls 8oz Ice Gel 12-count sold nationwide after investigators found insanitary conditions at the distributor's facility. A CGMP deviation allowed rodent exposure at the distribution center. Consumers and healthcare providers should stop using this product immediately and await guidance from Gold Star Distribution.
Cardinal Health recalled 1,169,726 chest drainage units on December 26, 2025. The recall stems from an update to the instructions for use (IFU) clarifying that the devices are intended for adults only. Using these devices on infants may result in delayed treatment and prolonged hospitalization.
Gold Star Distribution recalls Aleve 60-count pain relievers distributed nationwide due to CGMP deviations and insanitary conditions at its distribution center. Rodent exposure and activity were reported at the facility. Consumers and healthcare providers should stop using the product immediately and contact Gold Star Distribution for guidance.
Gold Star Distribution is recalling Tylenol products distributed nationwide. The recall concerns CGMP deviations and insanitary conditions at the distributor’s facility. Consumers should stop using these Tylenol products immediately and contact Gold Star Distribution for guidance.
Gold Star Distribution recalls 12 deodorant and body spray SKUs distributed nationwide after CGMP deviations created insanitary conditions at the distribution center. Rodent exposure and activity were cited as the core issues. Consumers should stop using the products immediately and follow the recall guidance from the distributor.
Gold Star Distribution is recalling all Halls cough drops distributed nationwide. The recall covers multiple SKUs including Menthol 12-count bags and Vitamin C 20-count lozenges. The root cause cited is CGMP deviations with insanitary conditions and rodent exposure at the distribution center. Consumers should stop using these products and follow recall instructions from Gold Star Distribution.
Lucky Ice Cool Mouthwash is being recalled nationwide in the United States. The action targets all lots distributed by Gold Star Distribution due to CGMP deviations and insanitary conditions, including rodent exposure in the distribution center. Consumers should stop using the product immediately and contact Gold Star Distribution for guidance.
Gold Star Distribution recalled Benadryl on December 26, 2025, due to insanitary conditions linked to rodent activity. The recall impacts all lots within expiry distributed by the company. Consumers should stop using the product immediately and contact their healthcare provider for guidance.